Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (1-10 of 385) with videos related to

Pageof 39
Sort By:
The EMBO Journal|September 28, 2016
T-lymphoid progenitors - we know what they are, but know not what they may beLars Bullinger
Blood|May 1, 2025
Mixed-phenotype acute leukemia revisited: omics lead the wayLars Bullinger
Blood|February 16, 2019
IDH2 inhibition: another piece to the puzzleLars Bullinger
Haematologica|June 14, 2006
Gene expression profiling in acute myeloid leukemiaLars Bullinger
Blood|January 6, 2022
CEBPA mutations in AML: site mattersLars Bullinger
Advances in Experimental Medicine and Biology|September 28, 2018
Circular RNAs in CancerSusanne Lux, Lars Bullinger
Seminars in Cancer Biology|April 25, 2021
Precision medicine in myeloid malignanciesJörg Westermann, Lars Bullinger
Seminars in Oncology|February 1, 2012
Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insightsLars Bullinger, Stefan Fröhling
Seminars in Hematology|November 14, 2025
Updates on current and future research in acute myeloid leukemiaFrederik Damm, Lars Bullinger
Experimental Hematology|April 22, 2014
Expression profiling of leukemia patients: key lessons and future directionsVelizar Shivarov, Lars Bullinger
Pageof 39

Showing results (1-10 of 385) with videos related to

Sort By:
Pageof 39
The EMBO Journal|September 28, 2016
T-lymphoid progenitors - we know what they are, but know not what they may beLars Bullinger
Blood|May 1, 2025
Mixed-phenotype acute leukemia revisited: omics lead the wayLars Bullinger
Blood|February 16, 2019
IDH2 inhibition: another piece to the puzzleLars Bullinger
Haematologica|June 14, 2006
Gene expression profiling in acute myeloid leukemiaLars Bullinger
Blood|January 6, 2022
CEBPA mutations in AML: site mattersLars Bullinger
Advances in Experimental Medicine and Biology|September 28, 2018
Circular RNAs in CancerSusanne Lux, Lars Bullinger
Seminars in Cancer Biology|April 25, 2021
Precision medicine in myeloid malignanciesJörg Westermann, Lars Bullinger
Seminars in Oncology|February 1, 2012
Array-based cytogenetic approaches in acute myeloid leukemia: clinical impact and biological insightsLars Bullinger, Stefan Fröhling
Seminars in Hematology|November 14, 2025
Updates on current and future research in acute myeloid leukemiaFrederik Damm, Lars Bullinger
Experimental Hematology|April 22, 2014
Expression profiling of leukemia patients: key lessons and future directionsVelizar Shivarov, Lars Bullinger
Pageof 39